These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26938683)

  • 21. Reintervention and survival in 1428 patients in the Australian and New Zealand Fontan Registry.
    Daley M; du Plessis K; Zannino D; Hornung T; Disney P; Cordina R; Grigg L; Radford DJ; Bullock A; d'Udekem Y
    Heart; 2020 May; 106(10):751-757. PubMed ID: 31662333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation.
    Heck PB; Müller J; Weber R; Hager A
    Eur J Heart Fail; 2013 Jun; 15(6):644-9. PubMed ID: 23610138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation.
    Goldstein BH; Connor CE; Gooding L; Rocchini AP
    Am J Cardiol; 2010 Apr; 105(8):1169-75. PubMed ID: 20381672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure.
    Margossian R; Sleeper LA; Pearson GD; Barker PC; Mertens L; Quartermain MD; Su JT; Shirali G; Chen S; Colan SD;
    J Am Soc Echocardiogr; 2016 Nov; 29(11):1066-1073. PubMed ID: 27624592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility and pregnancy in the Fontan population.
    Zentner D; Kotevski A; King I; Grigg L; d'Udekem Y
    Int J Cardiol; 2016 Apr; 208():97-101. PubMed ID: 26836494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion.
    Ballweg JA; Dominguez TE; Ravishankar C; Gaynor JW; Nicolson SC; Spray TL; Tabbutt S
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):537-44. PubMed ID: 20723722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of Fontan operation in patients with atrioventricular valve regurgitation.
    Podzolkov VP; Chiaureli MR; Yurlov IA; Zelenikin MM; Kovalev DV; Dontsova VI; Astrakhantseva TO; Putiato NA; Zaets SB
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):308-14; discussion 314-5. PubMed ID: 25527172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fontan conversion to one and one half ventricle repair.
    Sharma V; Burkhart HM; Cetta F; Hagler DJ; Phillips SD; Dearani JA
    Ann Thorac Surg; 2012 Oct; 94(4):1269-74; discussion 1274. PubMed ID: 22727323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current outcomes of the bi-directional cavopulmonary anastomosis in single ventricle patients: analysis of risk factors for morbidity and mortality, and suitability for Fontan completion.
    François K; Vandekerckhove K; De Groote K; Panzer J; De Wolf D; De Wilde H; Bové T
    Cardiol Young; 2016 Feb; 26(2):288-97. PubMed ID: 25704070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bidirectional cavopulmonary shunt with additional pulmonary blood flow: a failed or successful strategy?
    Gérelli S; Boulitrop C; Van Steenberghe M; Maldonado D; Bojan M; Raisky O; Sidi D; Vouhé PR
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):513-9. PubMed ID: 22368190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients.
    Daems JJN; Attard C; Van Den Helm S; Breur J; D'Udekem Y; du Plessis K; Wilson TG; Winlaw D; Gentles TL; Monagle P; Ignjatovic V
    Open Heart; 2021 May; 8(1):. PubMed ID: 33972403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Month Enalapril Treatment in Pediatric Fontan Patients With Moderate to Good Systolic Ventricular Function.
    Harteveld LM; Blom NA; Terol Espinosa de Los Monteros C; Kuipers IM; Rammeloo LAJ; Hazekamp MG; van Dijk JG; Ten Harkel ADJ
    Am J Cardiol; 2022 Jan; 163():98-103. PubMed ID: 34774285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
    Bart BA; Ertl G; Held P; Kuch J; Maggioni AP; McMurray J; Michelson EL; Rouleau JL; Warner Stevenson L; Swedberg K; Young JB; Yusuf S; Sellers MA; Granger CB; Califf RM; Pfeffer MA
    Eur Heart J; 1999 Aug; 20(16):1182-90. PubMed ID: 10448027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
    Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
    Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing the intermediate outcome in patients with single-ventricle physiology after Fontan operation.
    Nosal M; Valentik P; Kantorova A; Nagi AS; Sagat M; Poruban R
    Bratisl Lek Listy; 2010; 111(7):373-7. PubMed ID: 20806541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical outcome of atrial isomerism after univentricular repair.
    Hoashi T; Ichikawa H; Fukushima N; Ueno T; Kogaki S; Sawa Y
    J Card Surg; 2009; 24(1):19-23. PubMed ID: 18778300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.
    Hsu DT; Mital S; Ravishankar C; Margossian R; Li JS; Sleeper LA; Williams RV; Levine JC; McCrindle BW; Atz AM; Servedio D; Mahony L;
    Am Heart J; 2009 Jan; 157(1):37-45. PubMed ID: 19081394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pacemakers are associated with a higher risk of late death and transplantation in the Fontan population.
    Poh CL; Celermajer DS; Grigg LE; Kalman JM; McGuire MA; Gentles TL; Radford DJ; Bullock A; Disney PJS; Winlaw D; du Plessis K; d'Udekem Y
    Int J Cardiol; 2019 May; 282():33-37. PubMed ID: 30755335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.